Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department

Ali Kemal Erenler; Derya Yapar; Özlem Terzi

doi:10.5798/dicletip.319750

Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department

Öz

Objective: Sepsis and severe sepsis (sepsis accompanied by acute organ dysfunction) are leading causes of death
worldwide. In this study, our aim was to investigate utility of biomarkers commonly used in diagnosis of sepsis in
discriminating these two entities.
Methods: Two-hundred and three patients involved were divided into 2 subgroups as sepsis and severe sepsis
according to Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock:
2012. Then groups were compared according to clinical and laboratory (including C-reactive protein (CRP) and
procalcitonin (PCT) levels) characteristics.
Results: Of 203 patients included into the study, 124 (61.1%) were male and 79 (38.9%) were female. The most
common reason for sepsis was urinary tract infection (n=64, 31.5%), followed by catheter infection (n=16, 7.9%) and
pneumonia (n=14, 6.9%). Escherichia coli was the most common agent in both blood and urinary cultures. Majority of
the patients were treated with ceftriaxone (n=33, 16.3%), followed by meronem/dapson (n=25, 12.3%). In both
groups, CRP and PCT levels were high, even higher in severe sepsis group. However, any statistical significance could
not be determined between groups. Mortality rate in sepsis patients was 6.4%.
Conclusion: Plasma levels of both markers elevate in sepsis and severe sepsis. It was determined that CRP and PCT is
higher in severe sepsis than in sepsis. However, the difference is not statistically significant. Plasma levels of CRP and
PCT are not useful in differential diagnosis of sepsis and severe sepsis.

Anahtar Kelimeler

C-reactive protein,procalcitonin,sepsis,severe sepsis

Kaynakça

1. Vincent JL. We should abandon randomized controlled trials in the intensive care unit. Critical CareMedicine. 2010; 38: 534–8.
2. Protti A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care. 2006; 10: 228.
3. Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013; 17:R244.
4. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997; 16:735–47.
5. Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol. 2010;48: 2325–9.
6. Dellinger RP, Levy MM, Rhodes A, Annane D. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39:165-228.
7. Angele MK, Pratschke S, Hubbard WJ, et al. Gender differences in sepsis: cardiovascular and immunological aspects. Virulence. 2014;5:12-9.
8. Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA. 2014; 311: 844-54.

9. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5:4-11.
10. Yilmaz, G. R, Guven, T, Guner, R, et al. Growing fungal etiology in catheter-associated urinary tract infection: 2008-2013. IJID. 2014; 21:414.
11. Calandra T, Cohen J. The international sepsis forum consensus conference on defi¬nitions of infection in the intensive care unit. Crit Care Med. 2005; 33:1538–48.
12. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006; 34:344–53.
13. Martin-Loeches I, Levy MM, Artigas A. Management of severe sepsis: advances, challenges, and current status. Drug Des Devel Ther. 2015; 9:2079-88.
14. Bloos F, Reinhart K. Rapid diagnosis of sepsis.Virulence. 2014; 5:154-60.
15. Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and metaanalysis. Lancet Infect Dis. 2007; 7:210-7.
16. Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000; 28:977–83.
17. Erenler AK, Yardan T. Presepsin (sCD14-ST) as a biomarker of sepsis in clinical practice and in emergency department: a mini review. Laboratoriums Medizin. DOI 10.1515/labmed-2015-0072.
18. Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: A randomised, double-blind, placebo-controlled trial. Lancet. 2011; 377: 2023–30.
19. Gaieski DF, Edwards JM, Kallan MJ, et al.Benchmarking the incidence and mortality of severe sepsis in the united states. Critical CareMedicine. 2013;4: 1167–74.
20. Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160, Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Agency for Health Care Policy and Research, Rockville, Md, USA, 2006–2013.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

Araştırma Makalesi

Yazarlar

Ali Kemal Erenler
Türkiye

Derya Yapar Bu kişi benim
Türkiye

Özlem Terzi Bu kişi benim
Türkiye

Yayımlanma Tarihi

7 Haziran 2017

Gönderilme Tarihi

7 Haziran 2017

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2017 Cilt: 44 Sayı: 2

DOI

https://doi.org/10.5798/dicletip.319750

IZ

https://izlik.org/JA44BM57PD

Kaynak Göster

RIS / Bibtex

APA

Erenler, A. K., Yapar, D., & Terzi, Ö. (2017). Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department. Dicle Medical Journal, 44(2), 175-182. https://doi.org/10.5798/dicletip.319750

AMA

1.Erenler AK, Yapar D, Terzi Ö. Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department. diclemedj. 2017;44(2):175-182. doi:10.5798/dicletip.319750

Chicago

Erenler, Ali Kemal, Derya Yapar, ve Özlem Terzi. 2017. “Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department”. Dicle Medical Journal 44 (2): 175-82. https://doi.org/10.5798/dicletip.319750.

EndNote

Erenler AK, Yapar D, Terzi Ö (01 Haziran 2017) Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department. Dicle Medical Journal 44 2 175–182.

IEEE

[1]A. K. Erenler, D. Yapar, ve Ö. Terzi, “Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department”, diclemedj, c. 44, sy 2, ss. 175–182, Haz. 2017, doi: 10.5798/dicletip.319750.

ISNAD

Erenler, Ali Kemal - Yapar, Derya - Terzi, Özlem. “Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department”. Dicle Medical Journal 44/2 (01 Haziran 2017): 175-182. https://doi.org/10.5798/dicletip.319750.

JAMA

1.Erenler AK, Yapar D, Terzi Ö. Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department. diclemedj. 2017;44:175–182.

MLA

Erenler, Ali Kemal, vd. “Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department”. Dicle Medical Journal, c. 44, sy 2, Haziran 2017, ss. 175-82, doi:10.5798/dicletip.319750.

Vancouver

1.Ali Kemal Erenler, Derya Yapar, Özlem Terzi. Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department. diclemedj. 01 Haziran 2017;44(2):175-82. doi:10.5798/dicletip.319750

Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department

Comparison of Procalcitonin and C-reactive Protein in Differential Diagnosis of Sepsis and Severe Sepsis in Emergency Department

Öz

Anahtar Kelimeler

Kaynakça

Ayrıntılar

Birincil Dil

Konular

Bölüm

Yazarlar

Yayımlanma Tarihi

Gönderilme Tarihi

Kabul Tarihi

Yayımlandığı Sayı

DOI

IZ

Kaynak Göster

Cited By

Alpha-lipoic acid alleviates lipopolysaccharide-induced liver damage in rats via antioxidant effect

Early biochemical predictors of sepsis in patients with burn injury: current status and future perspectives

Predicting early mortality after CPR in the ICU: a multimodal analytical approach